ICD-10-CM Billable Code

B60.1

Acanthamebiasis

Clinical Classification Guidelines

Medical Intelligence & Overview

Acanthamebiasis is a rare parasitic infection caused by the ameba Acanthamoeba. This microorganism can be found in natural water sources, soil, and air, and it can infect humans through various routes. While most people are exposed to Acanthamoeba without issues, those with weakened immune systems or lens wearers are at increased risk. It can affect different parts of the body, most notably the eyes and the brain, leading to serious health complications if not diagnosed and treated promptly.

Causes & Symptoms

Clinical Causes: Contact with contaminated water sources, such as lakes, hot tubs, or swimming pools Poor hygiene or contaminated contact lenses, especially if lenses are not properly disinfected Exposure to contaminated soil or dust Inhalation of infectious aerosols from the environment Immunocompromised conditions that weaken the body's defenses

Key Symptoms: Eye pain, redness, and blurred vision, especially in contact lens wearers Sensitivity to light (photophobia) Corneal ulcers or keratitis, which may lead to vision loss if untreated Headache and fever when the infection involves the central nervous system Altered mental status or neurological deficits in brain infections Seizures or neurological disturbances in severe cases

Diagnostic & Treatment

Diagnosis Path: Diagnosing acanthamebiasis involves a combination of clinical evaluation and laboratory tests. Eye infections may be confirmed through microscopic examination of corneal scrapings, culture, or PCR testing. Central nervous system involvement typically requires neuroimaging such as MRI or CT scans, combined with cerebrospinal fluid analysis. Due to its rarity, specialized laboratory testing and close collaboration with infectious disease experts are often necessary for accurate diagnosis.

Treatment Protocols: Treatment strategies depend on the infection location and severity. For eye infections, topical anti-amebic agents are typically prescribed, sometimes alongside corticosteroids to reduce inflammation. Brain infections require systemic anti-amebic medications, which may include drugs like miltefosine, amphotericin B, or chlorhexidine. Early diagnosis and aggressive treatment are critical for improving outcomes. Due to the complex nature of these infections, management is usually coordinated by specialists in infectious diseases or neurology.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is B60.1 a billable ICD-10 code?
Yes, B60.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report B60.1?
Clinical documentation must specify the nature of Acanthamebiasis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

acanthamebiasis